Lu Hongbo

Lu Hongbo is listed in filings as Director at Arrowhead Pharmaceuticals Inc. This profile follows SEC Form 4 activity through May 14, 2026, including sale activity and purchase activity. Recent filings connect the profile to Arrowhead Pharmaceuticals Inc (ARWR), Zenas BioPharma, Inc. (ZBIO), and Terns Pharmaceuticals, Inc. (TERN). The current snapshot covers public activity from Jun 14, 2024 to May 14, 2026. Reported amounts are shown as $228.3K to $70.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.